US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 12.180
  • -0.080-0.65%
Close Nov 27 16:00 ET
  • 12.180
  • 0.0000.00%
Post 20:01 ET
70.15MMarket Cap-481P/E (TTM)

Atara Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
1,779.79%40.19M
2,892.69%28.64M
2,131.40%27.36M
-86.51%8.57M
1,823.98%4.25M
-52.05%2.14M
-98.14%957K
-83.24%1.23M
212.55%63.57M
-97.07%221K
Operating revenue
1,779.79%40.19M
2,892.69%28.64M
2,131.40%27.36M
-86.51%8.57M
1,823.98%4.25M
-52.05%2.14M
-98.14%957K
-83.24%1.23M
212.55%63.57M
-97.07%221K
Cost of revenue
190.71%7.6M
59.83%4.63M
818.98%1.99M
8.89M
3.16M
2.62M
2.9M
216K
0
0
Gross profit
6,931.87%32.59M
1,339.06%24.01M
2,412.08%25.37M
-100.49%-313K
394.12%1.09M
-110.70%-477K
-103.76%-1.94M
-86.19%1.01M
63.57M
221K
Operating expense
-21.39%54.35M
-39.20%42.24M
-25.53%56.62M
-19.88%275.69M
-19.41%61.05M
-22.39%69.14M
-17.00%69.48M
-20.42%76.03M
-4.63%344.09M
-24.95%75.76M
Selling and administrative expenses
-14.91%10.42M
-33.17%8.91M
-19.89%11.11M
-28.85%50.91M
-13.52%11.45M
-35.28%12.25M
-29.12%13.34M
-32.57%13.87M
-9.20%71.55M
-39.29%13.25M
-General and administrative expense
-14.91%10.42M
-33.17%8.91M
-19.89%11.11M
-28.85%50.91M
-13.52%11.45M
-35.28%12.25M
-29.12%13.34M
-32.57%13.87M
-9.20%71.55M
-39.29%13.25M
Research and development costs
-22.79%43.92M
-40.63%33.33M
-26.79%45.51M
-17.52%224.79M
-20.66%49.6M
-18.91%56.89M
-13.49%56.14M
-17.08%62.16M
-3.36%272.53M
-21.00%62.52M
Operating profit
68.75%-21.76M
74.47%-18.23M
58.35%-31.25M
1.61%-276.01M
20.62%-59.96M
17.74%-69.61M
-122.25%-71.41M
14.96%-75.02M
17.61%-280.51M
19.13%-75.54M
Net non-operating interest income expense
-309.04%-724K
-356.15%-812K
-217.81%-549K
-94.75%141K
-144.80%-465K
-120.82%-177K
-44.87%317K
108.04%466K
631.88%2.69M
1,135.71%1.04M
Non-operating interest income
-62.32%459K
-73.45%450K
-66.48%604K
77.38%5.43M
-38.44%711K
25.18%1.22M
140.77%1.7M
690.35%1.8M
733.51%3.06M
--1.16M
Non-operating interest expense
-15.20%1.18M
-8.42%1.26M
-13.70%1.15M
1,316.89%5.29M
905.13%1.18M
1,034.15%1.4M
968.22%1.38M
33,300.00%1.34M
--373K
--117K
Other net income (expense)
2,155.56%555K
40.00%-6K
134.52%68K
-100.50%-246K
82.61%-12K
91.26%-27K
-100.02%-10K
-80.73%-197K
49.54M
-69K
Special income (charges)
----
----
----
--0
----
----
----
----
--50.24M
--0
-Gain on sale of property,plant,equipment
----
----
----
--0
----
----
----
----
--50.24M
--0
Other non- operating income (expenses)
2,155.56%555K
40.00%-6K
134.52%68K
64.86%-246K
82.61%-12K
91.26%-27K
95.33%-10K
-80.73%-197K
---700K
---69K
Income before tax
68.59%-21.93M
73.21%-19.05M
57.55%-31.73M
-20.95%-276.11M
18.95%-60.44M
16.97%-69.82M
-485.07%-71.11M
15.16%-74.75M
32.87%-228.29M
20.09%-74.57M
Income tax
10.53%-17K
0
9.09%24K
25.00%15K
450.00%11K
-290.00%-19K
1K
22K
-73.91%12K
-93.33%2K
Net income
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
Net income continuous Operations
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
Minority interest income
Net income attributable to the parent company
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
Basic earnings per share
82.13%-2.93
81.67%-3.1
68.06%-5.75
-16.52%-65.25
22.33%-13.98
20.00%-16.4
-475.78%-16.91
17.24%-18
38.29%-56
25.00%-18
Diluted earnings per share
82.13%-2.93
81.67%-3.1
68.06%-5.75
-16.52%-65.25
22.33%-13.98
20.00%-16.4
-475.78%-16.91
17.24%-18
38.29%-56
25.00%-18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 1,779.79%40.19M2,892.69%28.64M2,131.40%27.36M-86.51%8.57M1,823.98%4.25M-52.05%2.14M-98.14%957K-83.24%1.23M212.55%63.57M-97.07%221K
Operating revenue 1,779.79%40.19M2,892.69%28.64M2,131.40%27.36M-86.51%8.57M1,823.98%4.25M-52.05%2.14M-98.14%957K-83.24%1.23M212.55%63.57M-97.07%221K
Cost of revenue 190.71%7.6M59.83%4.63M818.98%1.99M8.89M3.16M2.62M2.9M216K00
Gross profit 6,931.87%32.59M1,339.06%24.01M2,412.08%25.37M-100.49%-313K394.12%1.09M-110.70%-477K-103.76%-1.94M-86.19%1.01M63.57M221K
Operating expense -21.39%54.35M-39.20%42.24M-25.53%56.62M-19.88%275.69M-19.41%61.05M-22.39%69.14M-17.00%69.48M-20.42%76.03M-4.63%344.09M-24.95%75.76M
Selling and administrative expenses -14.91%10.42M-33.17%8.91M-19.89%11.11M-28.85%50.91M-13.52%11.45M-35.28%12.25M-29.12%13.34M-32.57%13.87M-9.20%71.55M-39.29%13.25M
-General and administrative expense -14.91%10.42M-33.17%8.91M-19.89%11.11M-28.85%50.91M-13.52%11.45M-35.28%12.25M-29.12%13.34M-32.57%13.87M-9.20%71.55M-39.29%13.25M
Research and development costs -22.79%43.92M-40.63%33.33M-26.79%45.51M-17.52%224.79M-20.66%49.6M-18.91%56.89M-13.49%56.14M-17.08%62.16M-3.36%272.53M-21.00%62.52M
Operating profit 68.75%-21.76M74.47%-18.23M58.35%-31.25M1.61%-276.01M20.62%-59.96M17.74%-69.61M-122.25%-71.41M14.96%-75.02M17.61%-280.51M19.13%-75.54M
Net non-operating interest income expense -309.04%-724K-356.15%-812K-217.81%-549K-94.75%141K-144.80%-465K-120.82%-177K-44.87%317K108.04%466K631.88%2.69M1,135.71%1.04M
Non-operating interest income -62.32%459K-73.45%450K-66.48%604K77.38%5.43M-38.44%711K25.18%1.22M140.77%1.7M690.35%1.8M733.51%3.06M--1.16M
Non-operating interest expense -15.20%1.18M-8.42%1.26M-13.70%1.15M1,316.89%5.29M905.13%1.18M1,034.15%1.4M968.22%1.38M33,300.00%1.34M--373K--117K
Other net income (expense) 2,155.56%555K40.00%-6K134.52%68K-100.50%-246K82.61%-12K91.26%-27K-100.02%-10K-80.73%-197K49.54M-69K
Special income (charges) --------------0------------------50.24M--0
-Gain on sale of property,plant,equipment --------------0------------------50.24M--0
Other non- operating income (expenses) 2,155.56%555K40.00%-6K134.52%68K64.86%-246K82.61%-12K91.26%-27K95.33%-10K-80.73%-197K---700K---69K
Income before tax 68.59%-21.93M73.21%-19.05M57.55%-31.73M-20.95%-276.11M18.95%-60.44M16.97%-69.82M-485.07%-71.11M15.16%-74.75M32.87%-228.29M20.09%-74.57M
Income tax 10.53%-17K09.09%24K25.00%15K450.00%11K-290.00%-19K1K22K-73.91%12K-93.33%2K
Net income 68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M
Net income continuous Operations 68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M
Minority interest income
Net income attributable to the parent company 68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M
Basic earnings per share 82.13%-2.9381.67%-3.168.06%-5.75-16.52%-65.2522.33%-13.9820.00%-16.4-475.78%-16.9117.24%-1838.29%-5625.00%-18
Diluted earnings per share 82.13%-2.9381.67%-3.168.06%-5.75-16.52%-65.2522.33%-13.9820.00%-16.4-475.78%-16.9117.24%-1838.29%-5625.00%-18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data